Mixed Small Vessel Disease in a Patient with Dementia with Lewy Bodies
Abstract
:1. Introduction
2. Materials and Methods
2.1. Study Details
2.2. Neuroimaging
2.3. CSF Sampling and Biomarker Analysis
3. Results
3.1. Patient Description
3.2. Neuroimaging
3.3. CSF Analysis
4. Discussion
5. Conclusions
Author Contributions
Funding
Conflicts of Interest
References
- Yamada, M. Cerebral amyloid angiopathy: Emerging concepts. J. Stroke 2015, 17, 17–30. [Google Scholar] [CrossRef] [PubMed]
- Yamada, M. The spectrum of cerebral amyloid angiopathy-related disorders. Intern. Med. 2014, 53, 1893–1894. [Google Scholar] [CrossRef] [PubMed]
- Yamada, M. Predicting cerebral amyloid angiopathy-related intracerebral hemorrhages and other cerebrovascular disorders in Alzheimer’s disease. Front. Neurol. 2012, 3, 64. [Google Scholar] [CrossRef] [PubMed]
- Attems, J.; Jellinger, K.A. The overlap between vascular disease and Alzheimer’s disease—Lessons from pathology. BMC Med. 2014, 12, 206. [Google Scholar] [CrossRef]
- Jellinger, K.A.; Attems, J. Neuropathological evaluation of mixed dementia. J. Neurol. Sci. 2007, 257, 80–87. [Google Scholar] [CrossRef]
- McKeith, I.G.; Boeve, B.F.; Dickson, D.W.; Halliday, G.; Taylor, J.P.; Weintraub, D.; Aarsland, D.; Galvin, J.; Attems, J.; Ballard, C.G.; et al. Diagnosis and management of dementia with Lewy bodies: Fourth consensus report of the DLB Consortium. Neurology 2017, 89, 88–100. [Google Scholar] [CrossRef]
- Mollenhauer, B.; El-Agnaf, O.M.; Marcus, K.; Trenkwalder, C.; Schlossmacher, M.G. Quantification of alpha-synuclein in cerebrospinal fluid as a biomarker candidate: review of the literature and considerations for future studies. Biomark. Med. 2010, 4, 683–699. [Google Scholar] [CrossRef]
- Jellinger, K.A.; Attems, J. Prevalence and impact of vascular and Alzheimer pathologies in Lewy body disease. Acta Neuropathol. 2008, 115, 427–436. [Google Scholar] [CrossRef]
- Dugger, B.N.; Adler, C.H.; Shill, H.A.; Caviness, J.; Jacobson, S.; Driver-Dunckley, E.; Beach, T.G. Arizona Parkinson’s Disease Consortium. Concomitant pathologies among a spectrum of parkinsonian disorders. Parkinsonism Relat. Disord. 2014, 20, 525–529. [Google Scholar] [CrossRef]
- Sachdev, P.; Kalaria, R.; O’Brien, J.; Skoog, I.; Alladi, S.; Black, S.E.; Blacker, D.; Blazer, D.G.; Chen, C.; Chui, H.; et al. Diagnostic criteria for vascular cognitive disorders: A VASCOG statement. Alzheimer Dis. Assoc. Disord. 2014, 28, 206–218. [Google Scholar] [CrossRef]
- Del Campo, M.; Mollenhauer, B.; Bertolotto, A.; Engelborghs, S.; Hampel, H.; Simonsen, A.H.; Kapaki, E.; Kruse, N.; Le Bastard, N.; Lehmann, S.; et al. Recommendations to standardize preanalytical confounding factors in Alzheimer’s and Parkinson’s disease cerebrospinal fluid biomarkers: An update. Biomark. Med. 2012, 6, 419–430. [Google Scholar] [CrossRef] [PubMed]
- Bourbouli, M.; Kapaki, E.; Petropoulou, O.; Paraskevas, G.P. Improved Performance of CSF Dementia Biomarker Measurements Over Time: The Effect of Quality Control and Harmonization Programs. Biomark. Applic. 2018, 2018, BMAP-126. [Google Scholar] [CrossRef]
- Paraskevas, G.P.; Kaselimis, D.; Kourtidou, E.; Constantinides, V.; Bougea, A.; Potagas, C.; Evdokimidis, I.; Kapaki, E. Cerebrospinal Fluid Biomarkers as a Diagnostic Tool of the Underlying Pathology of Primary Progressive Aphasia. J. Alzheimers Dis. 2017, 55, 1453–1461. [Google Scholar] [CrossRef] [PubMed]
- Folstein, M.; Folstein, S.; McHugh, P.R. Mini-Mental State: A practical method for grading the cognitive state of patients for the clinician. J. Psychiatr. Res. 1975, 12, 189–198. [Google Scholar] [CrossRef]
- Linn, J.; Halpin, A.; Demaerel, P.; Ruhland, J.; Giese, A.D.; Dichgans, M.; van Buchem, M.A.; Bruckmann, H.; Greenberg, S.M. Prevalence of superficial siderosis in patients with cerebral amyloid angiopathy. Neurology 2010, 74, 1346–1350. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Greenberg, S.M.; Charidimou, A. Diagnosis of Cerebral Amyloid Angiopathy: Evolution of the Boston Criteria. Stroke 2018, 49, 491–497. [Google Scholar] [CrossRef] [PubMed]
- Tsai, H.H.; Pasi, M.; Tsai, L.K.; Chen, Y.F.; Lee, B.C.; Tang, S.C.; Fotiadis, P.; Huang, C.Y.; Yen, R.F.; Jeng, J.S.; et al. Microangiopathy underlying mixed-location intracerebral hemorrhages/microbleeds: A PiB-PET study. Neurology 2019, 92, e774–e781. [Google Scholar] [CrossRef]
- Pasi, M.; Charidimou, A.; Boulouis, G.; Auriel, E.; Ayres, A.; Schwab, K.M.; Goldstein, J.N.; Rosand, J.; Viswanathan, A.; Pantoni, L.; et al. Mixed-location cerebral hemorrhage/microbleeds: Underlying microangiopathy and recurrence risk. Neurology 2018, 90, e119–e126. [Google Scholar] [CrossRef] [PubMed]
- De Reuck, J. The Impact of Cerebral Amyloid Angiopathy in Various Neurodegenerative Dementia Syndromes: A Neuropathological Study. Neurol. Res. Int. 2019, 2019, 7247325. [Google Scholar] [CrossRef]
- De Reuck, J.; Deramecourt, V.; Cordonnier, C.; Leys, D.; Pasquier, F.; Maurage, C.A. Prevalence of cerebrovascular lesions in patients with Lewy body dementia: A neuropathological study. Clin. Neurol. Neurosurg. 2013, 115, 1094–1097. [Google Scholar] [CrossRef]
- Simonsen, A.H.; Herukka, S.K.; Andreasen, N.; Baldeiras, I.; Bjerke, M.; Blennow, K.; Engelborghs, S.; Frisoni, G.B.; Gabryelewicz, T.; Galluzzi, S.; et al. Recommendations for CSF AD biomarkers in the diagnostic evaluation of dementia. Alzheimer’s Dement. 2017, 13, 274–284. [Google Scholar] [CrossRef] [PubMed]
- Wallin, A.; Román, G.C.; Esiri, M.; Kettunen, P.; Svensson, J.; Paraskevas, G.P.; Kapaki, E. Update on Vascular Cognitive Impairment Associated with Subcortical Small-Vessel Disease. J. Alzheimers Dis. 2018, 62, 1417–1441. [Google Scholar] [CrossRef] [PubMed]
- Schade, S.; Mollenhauer, B. Biomarkers in biological fluids for dementia with Lewy bodies. Alzheimers Res. Ther. 2014, 6, 72. [Google Scholar] [CrossRef] [PubMed]
- Boyle, P.A.; Yu, L.; Nag, S.; Leurgans, S.; Wilson, R.S.; Bennett, D.A.; Schneider, J.A. Cerebral amyloid angiopathy and cognitive outcomes in community-based older persons. Neurology 2015, 85, 1930–1936. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Case, N.F.; Charlton, A.; Zwiers, A.; Batool, S.; McCreary, C.R.; Hogan, D.B.; Ismail, Z.; Zerna, C.; Coutts, S.B.; Frayne, R.; et al. Cerebral Amyloid Angiopathy Is Associated With Executive Dysfunction and Mild Cognitive Impairment. Stroke 2016, 47, 2010–2016. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Chung, C.P.; Chou, K.H.; Chen, W.T.; Liu, L.K.; Lee, W.J.; Chen, L.K.; Lin, C.P.; Wang, P.N. Strictly Lobar Cerebral Microbleeds Are Associated With Cognitive Impairment. Stroke 2016, 47, 2497–2502. [Google Scholar] [CrossRef] [Green Version]
- Gleason, A.; Hayhow, B.; Emmanuel, J.; Gaillard, F. Cerebral amyloid angiopathy presenting with neuropsychiatric symptoms. Aust. N. Z. J. Psychiatry 2014, 48, 779–780. [Google Scholar] [CrossRef]
- Paraskevas, G.P.; Constantinides, V.C.; Bougea, A.; Paraskevas, P.; Tsivgoulis, G.; Kapaki, E. Characteristics of patients with amyloid-beta-related cerebral amyloid angiopathy presenting in a dementia clinic. Int. J. Alzhei. Parkin. Dis. 2018, 1, 1–7. [Google Scholar]
© 2019 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
Share and Cite
Paraskevas, G.P.; Constantinides, V.C.; Pyrgelis, E.-S.; Kapaki, E. Mixed Small Vessel Disease in a Patient with Dementia with Lewy Bodies. Brain Sci. 2019, 9, 159. https://doi.org/10.3390/brainsci9070159
Paraskevas GP, Constantinides VC, Pyrgelis E-S, Kapaki E. Mixed Small Vessel Disease in a Patient with Dementia with Lewy Bodies. Brain Sciences. 2019; 9(7):159. https://doi.org/10.3390/brainsci9070159
Chicago/Turabian StyleParaskevas, George P., Vasilios C. Constantinides, Efstratios-Stylianos Pyrgelis, and Elisabeth Kapaki. 2019. "Mixed Small Vessel Disease in a Patient with Dementia with Lewy Bodies" Brain Sciences 9, no. 7: 159. https://doi.org/10.3390/brainsci9070159